Influenza virus damages the alveolar barrier by disrupting epithelial cell tight junctions
A major cause of respiratory failure during influenza A virus (IAV) infection is damage to the epithelial–endothelial barrier of the pulmonary alveolus. Damage to this barrier results in flooding of the alveolar lumen with proteinaceous oedema fluid, erythrocytes and inflammatory cells. To date, the...
Saved in:
Published in | The European respiratory journal Vol. 47; no. 3; pp. 954 - 966 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
01.03.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A major cause of respiratory failure during influenza A virus (IAV) infection is damage to the epithelial–endothelial barrier of the pulmonary alveolus. Damage to this barrier results in flooding of the alveolar lumen with proteinaceous oedema fluid, erythrocytes and inflammatory cells. To date, the exact roles of pulmonary epithelial and endothelial cells in this process remain unclear.
Here, we used an in vitro co-culture model to understand how IAV damages the pulmonary epithelial–endothelial barrier. Human epithelial cells were seeded on the upper half of a transwell membrane while human endothelial cells were seeded on the lower half. These cells were then grown in co-culture and IAV was added to the upper chamber.
We showed that the addition of IAV (H1N1 and H5N1 subtypes) resulted in significant barrier damage. Interestingly, we found that, while endothelial cells mounted a pro-inflammatory/pro-coagulant response to a viral infection in the adjacent epithelial cells, damage to the alveolar epithelial–endothelial barrier occurred independently of endothelial cells. Rather, barrier damage was associated with disruption of tight junctions amongst epithelial cells, and specifically with loss of tight junction protein claudin-4.
Taken together, these data suggest that maintaining epithelial cell integrity is key in reducing pulmonary oedema during IAV infection. |
---|---|
AbstractList | A major cause of respiratory failure during influenza A virus (IAV) infection is damage to the epithelial-endothelial barrier of the pulmonary alveolus. Damage to this barrier results in flooding of the alveolar lumen with proteinaceous oedema fluid, erythrocytes and inflammatory cells. To date, the exact roles of pulmonary epithelial and endothelial cells in this process remain unclear.Here, we used an in vitro co-culture model to understand how IAV damages the pulmonary epithelial-endothelial barrier. Human epithelial cells were seeded on the upper half of a transwell membrane while human endothelial cells were seeded on the lower half. These cells were then grown in co-culture and IAV was added to the upper chamber.We showed that the addition of IAV (H1N1 and H5N1 subtypes) resulted in significant barrier damage. Interestingly, we found that, while endothelial cells mounted a pro-inflammatory/pro-coagulant response to a viral infection in the adjacent epithelial cells, damage to the alveolar epithelial-endothelial barrier occurred independently of endothelial cells. Rather, barrier damage was associated with disruption of tight junctions amongst epithelial cells, and specifically with loss of tight junction protein claudin-4.Taken together, these data suggest that maintaining epithelial cell integrity is key in reducing pulmonary oedema during IAV infection. A major cause of respiratory failure during influenza A virus (IAV) infection is damage to the epithelial-endothelial barrier of the pulmonary alveolus. Damage to this barrier results in flooding of the alveolar lumen with proteinaceous oedema fluid, erythrocytes and inflammatory cells. To date, the exact roles of pulmonary epithelial and endothelial cells in this process remain unclear.Here, we used an in vitro co-culture model to understand how IAV damages the pulmonary epithelial-endothelial barrier. Human epithelial cells were seeded on the upper half of a transwell membrane while human endothelial cells were seeded on the lower half. These cells were then grown in co-culture and IAV was added to the upper chamber.We showed that the addition of IAV (H1N1 and H5N1 subtypes) resulted in significant barrier damage. Interestingly, we found that, while endothelial cells mounted a pro-inflammatory/pro-coagulant response to a viral infection in the adjacent epithelial cells, damage to the alveolar epithelial-endothelial barrier occurred independently of endothelial cells. Rather, barrier damage was associated with disruption of tight junctions amongst epithelial cells, and specifically with loss of tight junction protein claudin-4.Taken together, these data suggest that maintaining epithelial cell integrity is key in reducing pulmonary oedema during IAV infection.A major cause of respiratory failure during influenza A virus (IAV) infection is damage to the epithelial-endothelial barrier of the pulmonary alveolus. Damage to this barrier results in flooding of the alveolar lumen with proteinaceous oedema fluid, erythrocytes and inflammatory cells. To date, the exact roles of pulmonary epithelial and endothelial cells in this process remain unclear.Here, we used an in vitro co-culture model to understand how IAV damages the pulmonary epithelial-endothelial barrier. Human epithelial cells were seeded on the upper half of a transwell membrane while human endothelial cells were seeded on the lower half. These cells were then grown in co-culture and IAV was added to the upper chamber.We showed that the addition of IAV (H1N1 and H5N1 subtypes) resulted in significant barrier damage. Interestingly, we found that, while endothelial cells mounted a pro-inflammatory/pro-coagulant response to a viral infection in the adjacent epithelial cells, damage to the alveolar epithelial-endothelial barrier occurred independently of endothelial cells. Rather, barrier damage was associated with disruption of tight junctions amongst epithelial cells, and specifically with loss of tight junction protein claudin-4.Taken together, these data suggest that maintaining epithelial cell integrity is key in reducing pulmonary oedema during IAV infection. A major cause of respiratory failure during influenza A virus (IAV) infection is damage to the epithelial–endothelial barrier of the pulmonary alveolus. Damage to this barrier results in flooding of the alveolar lumen with proteinaceous oedema fluid, erythrocytes and inflammatory cells. To date, the exact roles of pulmonary epithelial and endothelial cells in this process remain unclear. Here, we used an in vitro co-culture model to understand how IAV damages the pulmonary epithelial–endothelial barrier. Human epithelial cells were seeded on the upper half of a transwell membrane while human endothelial cells were seeded on the lower half. These cells were then grown in co-culture and IAV was added to the upper chamber. We showed that the addition of IAV (H1N1 and H5N1 subtypes) resulted in significant barrier damage. Interestingly, we found that, while endothelial cells mounted a pro-inflammatory/pro-coagulant response to a viral infection in the adjacent epithelial cells, damage to the alveolar epithelial–endothelial barrier occurred independently of endothelial cells. Rather, barrier damage was associated with disruption of tight junctions amongst epithelial cells, and specifically with loss of tight junction protein claudin-4. Taken together, these data suggest that maintaining epithelial cell integrity is key in reducing pulmonary oedema during IAV infection. |
Author | Becker, Christin Zaaraoui-Boutahar, Fatiha Bárcena, Montserrat Kuiken, Thijs van der Aa, Stijn Koster, Abraham J. Scott, Dana P. Limpens, Ronald W.A.L. Kasper, Jennifer Goeijenbier, Marco Herold, Susanne Kirkpatrick, Charles James Short, Kirsty R. Fouchier, Ron A.M. Andeweg, Arno C. Richard, Mathilde |
Author_xml | – sequence: 1 givenname: Kirsty R. surname: Short fullname: Short, Kirsty R. – sequence: 2 givenname: Jennifer surname: Kasper fullname: Kasper, Jennifer – sequence: 3 givenname: Stijn surname: van der Aa fullname: van der Aa, Stijn – sequence: 4 givenname: Arno C. surname: Andeweg fullname: Andeweg, Arno C. – sequence: 5 givenname: Fatiha surname: Zaaraoui-Boutahar fullname: Zaaraoui-Boutahar, Fatiha – sequence: 6 givenname: Marco surname: Goeijenbier fullname: Goeijenbier, Marco – sequence: 7 givenname: Mathilde surname: Richard fullname: Richard, Mathilde – sequence: 8 givenname: Susanne surname: Herold fullname: Herold, Susanne – sequence: 9 givenname: Christin surname: Becker fullname: Becker, Christin – sequence: 10 givenname: Dana P. surname: Scott fullname: Scott, Dana P. – sequence: 11 givenname: Ronald W.A.L. surname: Limpens fullname: Limpens, Ronald W.A.L. – sequence: 12 givenname: Abraham J. surname: Koster fullname: Koster, Abraham J. – sequence: 13 givenname: Montserrat surname: Bárcena fullname: Bárcena, Montserrat – sequence: 14 givenname: Ron A.M. surname: Fouchier fullname: Fouchier, Ron A.M. – sequence: 15 givenname: Charles James surname: Kirkpatrick fullname: Kirkpatrick, Charles James – sequence: 16 givenname: Thijs surname: Kuiken fullname: Kuiken, Thijs |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26743480$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kD1PwzAQhi1URD_gFyAhjywpduw49ogqPipVYoGFJXKSS-vKSYrtIJVfT0JbBgaWu9PpeU-nZ4pGTdsAQteUzCmV7I4ypRghbE5oLOMoJjQ5Q5NhGw3rEZoQRVhEFRNjNPV-SwgVnNELNI5FyhmXZILel01lO2i-NP40rvO41LVeg8dhA1jbT2itdjjXzhno-x6XxrtuF0yzxrAzPWWNtrgAa3Ew603A264pgmkbf4nOK209XB37DL09PrwunqPVy9Nycb-KCk5FGCqppEhEGfMUpEpJBSUtaaFpAkkh0pjnTLFc5qJiKuWp7mcpBROEJxxyNkO3h7s713504ENWGz88pBtoO5_RVCgl45jIHr05ol1eQ5ntnKm122cnHz3ADkDhWu8dVL8IJdlgPTtZz36sZ4P1PqX-pAoT9CAhOG3sv9lvL_uFqw |
CitedBy_id | crossref_primary_10_1016_j_jointm_2024_02_002 crossref_primary_10_1128_mbio_01982_23 crossref_primary_10_1515_hsz_2018_0304 crossref_primary_10_3389_fmicb_2017_00861 crossref_primary_10_3390_v11020116 crossref_primary_10_1038_s41598_018_33180_w crossref_primary_10_3389_fphys_2021_691227 crossref_primary_10_1002_adhm_202100879 crossref_primary_10_1080_17425247_2024_2446608 crossref_primary_10_3390_pharmaceutics14122619 crossref_primary_10_1016_j_virol_2017_10_007 crossref_primary_10_1016_j_virol_2018_12_016 crossref_primary_10_11150_kansenshogakuzasshi_e23030 crossref_primary_10_3390_ijms241311230 crossref_primary_10_1016_j_cmi_2019_04_031 crossref_primary_10_3389_fimmu_2020_00003 crossref_primary_10_1007_s15010_024_02234_9 crossref_primary_10_1128_CMR_00103_20 crossref_primary_10_1038_s41586_021_03570_8 crossref_primary_10_1080_21688370_2021_1883965 crossref_primary_10_1097_TP_0000000000004959 crossref_primary_10_1002_jat_3918 crossref_primary_10_1016_j_bcp_2024_116547 crossref_primary_10_3389_fcell_2020_579157 crossref_primary_10_1016_j_arbr_2020_04_008 crossref_primary_10_1016_j_intimp_2023_110751 crossref_primary_10_3389_fmed_2022_1043859 crossref_primary_10_1016_j_ajpath_2024_06_004 crossref_primary_10_1016_j_radcr_2022_10_071 crossref_primary_10_1186_s12866_018_1307_4 crossref_primary_10_1038_s41564_019_0444_3 crossref_primary_10_1038_cddiscovery_2017_10 crossref_primary_10_1093_lambio_ovae029 crossref_primary_10_1002_rth2_12470 crossref_primary_10_3390_diagnostics12112712 crossref_primary_10_1016_j_celrep_2020_107801 crossref_primary_10_1002_advs_202004990 crossref_primary_10_3389_fimmu_2022_1056036 crossref_primary_10_1016_j_molmed_2021_07_008 crossref_primary_10_1016_j_jdsr_2023_12_006 crossref_primary_10_1186_s13054_024_05127_3 crossref_primary_10_1016_j_arbres_2020_04_019 crossref_primary_10_1111_lam_13649 crossref_primary_10_1165_rcmb_2016_0377OC crossref_primary_10_1038_s41401_021_00625_4 crossref_primary_10_1186_s12967_024_05376_4 crossref_primary_10_1093_glycob_cwae093 crossref_primary_10_3389_ftox_2022_840606 crossref_primary_10_1016_j_freeradbiomed_2023_03_016 crossref_primary_10_1111_myc_13369 crossref_primary_10_1016_j_freeradbiomed_2021_01_045 crossref_primary_10_1016_j_jep_2023_117231 crossref_primary_10_1134_S1990519X19040084 crossref_primary_10_3390_ijms25137042 crossref_primary_10_1002_cti2_1350 crossref_primary_10_1155_ina_8961340 crossref_primary_10_2147_IJN_S300594 crossref_primary_10_1016_j_ijpharm_2022_122024 crossref_primary_10_1080_1744666X_2021_1951233 crossref_primary_10_3389_fimmu_2018_01521 crossref_primary_10_1038_s41598_024_82516_2 crossref_primary_10_3201_eid2801_211636 crossref_primary_10_1186_s12931_019_1153_4 crossref_primary_10_1038_s41564_018_0278_4 crossref_primary_10_3390_v14010165 crossref_primary_10_1007_s00018_021_03889_5 crossref_primary_10_3390_pathogens8040265 crossref_primary_10_5713_ab_24_0117 crossref_primary_10_1038_s41598_017_07724_5 crossref_primary_10_1093_femspd_ftaa017 crossref_primary_10_3390_microorganisms13030572 crossref_primary_10_1093_bfgp_elac021 crossref_primary_10_1038_s41598_022_13637_9 crossref_primary_10_3389_fendo_2022_843152 crossref_primary_10_3389_fimmu_2021_770066 crossref_primary_10_1080_21688370_2021_1943274 crossref_primary_10_1096_fj_201901265R crossref_primary_10_1111_myc_13410 crossref_primary_10_1016_j_phrs_2022_106509 crossref_primary_10_1186_s12985_018_1045_0 crossref_primary_10_1038_s41572_019_0069_0 crossref_primary_10_3389_fmed_2020_607786 crossref_primary_10_3390_v10080392 crossref_primary_10_1073_pnas_1902840116 crossref_primary_10_3389_fphar_2021_735443 crossref_primary_10_1128_mBio_02068_16 crossref_primary_10_1371_journal_ppat_1012449 crossref_primary_10_3389_fimmu_2017_01644 crossref_primary_10_1371_journal_ppat_1010703 crossref_primary_10_4049_jimmunol_1600602 crossref_primary_10_1080_21688370_2023_2222628 crossref_primary_10_1371_journal_pone_0216056 crossref_primary_10_3390_pathogens11101200 crossref_primary_10_1128_mBio_02841_19 crossref_primary_10_1021_acsami_4c02918 crossref_primary_10_3389_falgy_2023_1093800 crossref_primary_10_1016_j_cimid_2021_101611 crossref_primary_10_1016_j_virs_2023_11_010 crossref_primary_10_1016_j_jprot_2021_104462 crossref_primary_10_3390_jof8080840 crossref_primary_10_1016_j_mib_2021_04_006 crossref_primary_10_2174_0929867329666220430125326 crossref_primary_10_3389_fimmu_2018_01421 crossref_primary_10_1038_s41467_023_44421_6 crossref_primary_10_1038_s41385_019_0206_9 crossref_primary_10_1042_CS20240220 crossref_primary_10_1242_jcs_259871 crossref_primary_10_1038_s42003_022_03131_3 crossref_primary_10_1016_j_intimp_2024_111864 crossref_primary_10_1016_S1473_3099_20_30847_1 crossref_primary_10_26508_lsa_202201837 crossref_primary_10_3390_microorganisms12122526 crossref_primary_10_1016_j_ymthe_2023_06_011 crossref_primary_10_1038_s41385_019_0188_7 crossref_primary_10_1016_j_mad_2025_112037 crossref_primary_10_3389_fimmu_2020_570681 crossref_primary_10_1186_s13567_021_01005_w crossref_primary_10_3390_ijms23062995 crossref_primary_10_1128_mBio_03269_20 crossref_primary_10_1093_infdis_jiae069 crossref_primary_10_1111_cea_12830 crossref_primary_10_3389_fimmu_2022_879575 crossref_primary_10_3390_v12060679 crossref_primary_10_1016_j_cophys_2020_10_008 crossref_primary_10_3346_jkms_2022_37_e134 crossref_primary_10_1016_j_vetmic_2021_109071 crossref_primary_10_1134_S207908642102002X crossref_primary_10_20340_vmi_rvz_2022_4_MORPH_3 crossref_primary_10_1038_s41420_024_01981_w crossref_primary_10_3390_jof9060666 crossref_primary_10_1016_j_bbrc_2023_03_002 crossref_primary_10_1186_s13020_020_00415_w crossref_primary_10_1016_j_ijpharm_2023_122667 crossref_primary_10_3389_fmicb_2023_1279159 crossref_primary_10_1111_pin_13268 crossref_primary_10_3390_v13071312 crossref_primary_10_7759_cureus_23755 crossref_primary_10_1111_myc_13693 crossref_primary_10_1186_s12879_021_06578_7 crossref_primary_10_1016_j_heliyon_2024_e24298 crossref_primary_10_1038_srep39668 crossref_primary_10_7554_eLife_56907 crossref_primary_10_1089_ars_2020_8028 crossref_primary_10_3390_ijms21239309 crossref_primary_10_1093_femspd_ftaa046 crossref_primary_10_3389_fmicb_2022_957830 crossref_primary_10_3390_biom12091273 crossref_primary_10_3390_ijms231710071 crossref_primary_10_1186_s12879_020_05584_5 crossref_primary_10_1002_ppul_24699 crossref_primary_10_1038_s41598_020_75113_6 crossref_primary_10_3390_ijms26072975 crossref_primary_10_1016_j_ccm_2024_08_004 crossref_primary_10_3390_v15102035 crossref_primary_10_1038_s41577_024_01029_1 crossref_primary_10_3389_fimmu_2024_1328453 crossref_primary_10_3390_v16101576 crossref_primary_10_3390_jcm13020346 crossref_primary_10_1002_advs_202500637 crossref_primary_10_3390_ijms22168790 crossref_primary_10_1093_infdis_jiz349 crossref_primary_10_1016_j_jfma_2022_07_006 crossref_primary_10_1155_2024_2237621 crossref_primary_10_1016_S0140_6736_21_00439_6 crossref_primary_10_1152_ajplung_00289_2024 crossref_primary_10_1055_s_0041_1736459 crossref_primary_10_3389_fcimb_2020_616475 |
Cites_doi | 10.1016/S0140-6736(02)11772-7 10.1186/1465-9921-10-102 10.1128/CDLI.10.3.495-497.2003 10.1128/JVI.05070-11 10.1186/1743-8977-8-6 10.1016/S0140-6736(07)61515-3 10.1016/j.virusres.2004.02.028 10.4161/viru.25779 10.1164/rccm.200801-136OC 10.3201/eid1305.060572 10.1128/JVI.06348-11 10.1007/s00011-015-0837-6 10.1073/pnas.83.12.4533 10.1084/jem.20080201 10.1371/journal.pone.0037886 10.1016/j.cell.2011.08.015 10.1152/ajplung.00077.2014 10.1016/j.vaccine.2008.07.025 10.1371/journal.pone.0069465 10.1091/mbc.E02-03-0134 10.1007/s00705-003-0208-4 10.1186/1471-2180-14-134 10.3389/fmicb.2014.00653 10.2353/ajpath.2010.100115 10.1016/S1473-3099(13)70286-X 10.1006/mvre.2002.2434 10.1177/0300985810378651 10.1155/2010/460607 10.1111/j.1749-6632.2012.06545.x 10.1128/JVI.00468-09 10.1128/JVI.01712-07 10.1021/mp4006535 10.1099/vir.0.18913-0 10.1128/JVI.76.18.9298-9306.2002 10.1002/eji.1830250113 10.1152/ajplung.00299.2010 10.1164/rccm.200909-1420OC 10.1016/j.bbamem.2008.08.027 10.1371/journal.pone.0047323 10.3389/fmicb.2015.00220 |
ContentType | Journal Article |
Copyright | Copyright ©ERS 2016. |
Copyright_xml | – notice: Copyright ©ERS 2016. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1183/13993003.01282-2015 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1399-3003 |
EndPage | 966 |
ExternalDocumentID | 26743480 10_1183_13993003_01282_2015 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .55 .GJ 18M 1OC 2WC 31~ 3O- 53G 5GY 5RE 5VS 8-1 AADJU AAFWJ AAYXX AAZMJ ABCQX ABJNI ABOCM ABSQV ACEMG ACGFO ACPRK ACXQS ADBBV ADDZX ADMOG ADYFA AENEX AFFNX AFHIN AFZJQ AIZTS AJAOE ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CAG CITATION COF CS3 DIK E3Z EBS EJD F5P F9R GX1 H13 INIJC J5H KQ8 L7B LH4 LW6 OK1 P2P PQQKQ R0Z RHI TER TR2 W8F WOQ X7M ZE2 ZGI ZXP ~02 CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c416t-c410f8656d247e8970fed1d1ca15e5c6724b393b8b6f39747a3b8886360454eb3 |
ISSN | 0903-1936 1399-3003 |
IngestDate | Thu Jul 10 17:07:40 EDT 2025 Mon Jul 21 05:57:36 EDT 2025 Sun Jul 06 05:03:27 EDT 2025 Thu Apr 24 23:00:21 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
License | Copyright ©ERS 2016. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c416t-c410f8656d247e8970fed1d1ca15e5c6724b393b8b6f39747a3b8886360454eb3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://erj.ersjournals.com/content/erj/47/3/954.full.pdf |
PMID | 26743480 |
PQID | 1769982208 |
PQPubID | 23479 |
PageCount | 13 |
ParticipantIDs | proquest_miscellaneous_1769982208 pubmed_primary_26743480 crossref_primary_10_1183_13993003_01282_2015 crossref_citationtrail_10_1183_13993003_01282_2015 |
PublicationCentury | 2000 |
PublicationDate | 2016-03-01 |
PublicationDateYYYYMMDD | 2016-03-01 |
PublicationDate_xml | – month: 03 year: 2016 text: 2016-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | The European respiratory journal |
PublicationTitleAlternate | Eur Respir J |
PublicationYear | 2016 |
References | 2024102023510008000_47.3.954.24 2024102023510008000_47.3.954.23 2024102023510008000_47.3.954.26 2024102023510008000_47.3.954.25 2024102023510008000_47.3.954.20 2024102023510008000_47.3.954.22 2024102023510008000_47.3.954.21 Short (2024102023510008000_47.3.954.10) 2014; 5 2024102023510008000_47.3.954.40 2024102023510008000_47.3.954.28 2024102023510008000_47.3.954.27 2024102023510008000_47.3.954.13 2024102023510008000_47.3.954.35 2024102023510008000_47.3.954.12 2024102023510008000_47.3.954.34 2024102023510008000_47.3.954.2 2024102023510008000_47.3.954.15 2024102023510008000_47.3.954.37 2024102023510008000_47.3.954.14 2024102023510008000_47.3.954.36 2024102023510008000_47.3.954.31 2024102023510008000_47.3.954.30 2024102023510008000_47.3.954.11 2024102023510008000_47.3.954.33 2024102023510008000_47.3.954.32 2024102023510008000_47.3.954.8 2024102023510008000_47.3.954.7 2024102023510008000_47.3.954.9 2024102023510008000_47.3.954.4 2024102023510008000_47.3.954.3 2024102023510008000_47.3.954.6 Gorin (2024102023510008000_47.3.954.1) 1979; 47 2024102023510008000_47.3.954.5 Brennan (2024102023510008000_47.3.954.41) 2010; 2010 2024102023510008000_47.3.954.17 2024102023510008000_47.3.954.39 2024102023510008000_47.3.954.16 Goeijenbier (2024102023510008000_47.3.954.29) 2015; 6 2024102023510008000_47.3.954.38 2024102023510008000_47.3.954.19 2024102023510008000_47.3.954.18 |
References_xml | – ident: 2024102023510008000_47.3.954.13 doi: 10.1016/S0140-6736(02)11772-7 – ident: 2024102023510008000_47.3.954.19 doi: 10.1186/1465-9921-10-102 – ident: 2024102023510008000_47.3.954.18 doi: 10.1128/CDLI.10.3.495-497.2003 – ident: 2024102023510008000_47.3.954.9 doi: 10.1128/JVI.05070-11 – ident: 2024102023510008000_47.3.954.25 doi: 10.1186/1743-8977-8-6 – ident: 2024102023510008000_47.3.954.34 doi: 10.1016/S0140-6736(07)61515-3 – ident: 2024102023510008000_47.3.954.28 doi: 10.1016/j.virusres.2004.02.028 – ident: 2024102023510008000_47.3.954.12 doi: 10.4161/viru.25779 – ident: 2024102023510008000_47.3.954.5 doi: 10.1164/rccm.200801-136OC – ident: 2024102023510008000_47.3.954.4 doi: 10.3201/eid1305.060572 – ident: 2024102023510008000_47.3.954.22 doi: 10.1128/JVI.06348-11 – ident: 2024102023510008000_47.3.954.15 doi: 10.1007/s00011-015-0837-6 – ident: 2024102023510008000_47.3.954.17 doi: 10.1073/pnas.83.12.4533 – ident: 2024102023510008000_47.3.954.37 doi: 10.1084/jem.20080201 – ident: 2024102023510008000_47.3.954.6 doi: 10.1371/journal.pone.0037886 – ident: 2024102023510008000_47.3.954.11 doi: 10.1016/j.cell.2011.08.015 – ident: 2024102023510008000_47.3.954.39 doi: 10.1152/ajplung.00077.2014 – ident: 2024102023510008000_47.3.954.24 doi: 10.1016/j.vaccine.2008.07.025 – ident: 2024102023510008000_47.3.954.7 doi: 10.1371/journal.pone.0069465 – ident: 2024102023510008000_47.3.954.14 doi: 10.1091/mbc.E02-03-0134 – ident: 2024102023510008000_47.3.954.20 doi: 10.1007/s00705-003-0208-4 – ident: 2024102023510008000_47.3.954.16 doi: 10.1186/1471-2180-14-134 – volume: 5 start-page: 653 year: 2014 ident: 2024102023510008000_47.3.954.10 article-title: Influenza virus and endothelial cells: a species specific relationship publication-title: Front Microbiol doi: 10.3389/fmicb.2014.00653 – ident: 2024102023510008000_47.3.954.23 doi: 10.2353/ajpath.2010.100115 – ident: 2024102023510008000_47.3.954.2 doi: 10.1016/S1473-3099(13)70286-X – ident: 2024102023510008000_47.3.954.27 doi: 10.1006/mvre.2002.2434 – ident: 2024102023510008000_47.3.954.35 doi: 10.1177/0300985810378651 – volume: 2010 start-page: 460607 year: 2010 ident: 2024102023510008000_47.3.954.41 article-title: Tight junctions: a barrier to the initiation and progression of breast cancer? publication-title: J Biomed Biotechnol doi: 10.1155/2010/460607 – ident: 2024102023510008000_47.3.954.38 doi: 10.1111/j.1749-6632.2012.06545.x – ident: 2024102023510008000_47.3.954.21 doi: 10.1128/JVI.00468-09 – volume: 47 start-page: 1315 year: 1979 ident: 2024102023510008000_47.3.954.1 article-title: Differential permeability of endothelial and epithelial barriers to albumin flux publication-title: J Appl Physiol Respir Environ Exerc Physiol – ident: 2024102023510008000_47.3.954.32 doi: 10.1128/JVI.01712-07 – ident: 2024102023510008000_47.3.954.26 doi: 10.1021/mp4006535 – ident: 2024102023510008000_47.3.954.30 doi: 10.1099/vir.0.18913-0 – ident: 2024102023510008000_47.3.954.31 doi: 10.1128/JVI.76.18.9298-9306.2002 – ident: 2024102023510008000_47.3.954.36 doi: 10.1002/eji.1830250113 – ident: 2024102023510008000_47.3.954.40 doi: 10.1152/ajplung.00299.2010 – ident: 2024102023510008000_47.3.954.3 doi: 10.1164/rccm.200909-1420OC – ident: 2024102023510008000_47.3.954.33 doi: 10.1016/j.bbamem.2008.08.027 – ident: 2024102023510008000_47.3.954.8 doi: 10.1371/journal.pone.0047323 – volume: 6 start-page: 220 year: 2015 ident: 2024102023510008000_47.3.954.29 article-title: Effect of Puumala hantavirus infection on human umbilical vein endothelial cell hemostatic function: platelet interactions, increased tissue factor expression and fibrinolysis regulator release publication-title: Front Microbiol doi: 10.3389/fmicb.2015.00220 |
SSID | ssj0016431 |
Score | 2.5679235 |
Snippet | A major cause of respiratory failure during influenza A virus (IAV) infection is damage to the epithelial–endothelial barrier of the pulmonary alveolus. Damage... A major cause of respiratory failure during influenza A virus (IAV) infection is damage to the epithelial-endothelial barrier of the pulmonary alveolus. Damage... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 954 |
SubjectTerms | Cell Line Coculture Techniques Cytokines - metabolism Epithelial Cells - pathology Epithelial Cells - virology Humans Influenza A Virus, H1N1 Subtype - pathogenicity Influenza A Virus, H5N1 Subtype - pathogenicity Pulmonary Alveoli - virology Tight Junctions - ultrastructure |
Title | Influenza virus damages the alveolar barrier by disrupting epithelial cell tight junctions |
URI | https://www.ncbi.nlm.nih.gov/pubmed/26743480 https://www.proquest.com/docview/1769982208 |
Volume | 47 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9NAEF_qCeKL-G39YgXfYmqa3SSbx3Iop8cJwh0cvoTd7AZaemlJkxPvz_EvdWaz-Tg9D8-XENJ2kmZ-mZ2ZzPyGkLd5qJWMdO6bXDOfF1HkqzhRvtASvQeeaEtgevQlPjjhn0-j08nk56hqqanVLL-4sq_kf7QKx0Cv2CV7A832QuEA7IN-YQsahu0_6fhTO2HkQnrny6rZeVqeScvZALqX63ODYaunZGWn0oGfqZe7qtnaQmezxWaMNebLMXfv1RikeytY5YYM3mpAUp-0r0av5sfXaFke3VT6wyW4lODbz3prLpGPfFxM032C3VPIZrGQbcnZctWDdVFq891YS7Soyo23PxtnKObxUKLVpRqx_i1ljvK6NbTgGPksCNjYErfcmw5xbGRW05Zo2q3QaTun5U_jL5CEAiWj4BkuvSHgpW0XvUy1_dsS2Bcm2pBIsKwTklkhGQq5RW6HEIqgLT38OrypAo_OTmXs_qNjtgIh76-4ksvez19CGuvaHN8n91xMQhctwB6QiSkfkjtHruriEfnW44xanFGHMwoIoh3OqMMZVT_ogDM64IwizqjFGe1x9picfPxwvH_gu5kcfg6ue43boBDwGOuQJ0akSVAYPdfzXM4jE-VxEnLFUqaEiguGsaqEfSGQlY5H3Cj2hOyVm9I8I5TLoEi5YFog7aRQ0mjOwXuXBQslWJYpCbt7leWOsB7npqyza7Q0Je_6H21bvpbrv_6mU0IGdhVvhCzNptll8yROkdsyEFPytNVOLzDEzh0uguc3O9kLcnd4PF6SvbpqzCtwaWv12mLqF3aUmvk |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Influenza+virus+damages+the+alveolar+barrier+by+disrupting+epithelial+cell+tight+junctions&rft.jtitle=The+European+respiratory+journal&rft.au=Short%2C+Kirsty+R.&rft.au=Kasper%2C+Jennifer&rft.au=van+der+Aa%2C+Stijn&rft.au=Andeweg%2C+Arno+C.&rft.date=2016-03-01&rft.issn=0903-1936&rft.eissn=1399-3003&rft.volume=47&rft.issue=3&rft.spage=954&rft.epage=966&rft_id=info:doi/10.1183%2F13993003.01282-2015&rft.externalDBID=n%2Fa&rft.externalDocID=10_1183_13993003_01282_2015 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0903-1936&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0903-1936&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0903-1936&client=summon |